收藏切换
Screening of active ingredients in Erzhi pill for osteoporosis based on molecular docking technology and verification
收藏切换
PDF
Yuan-yuan ZHAI, Xin LI, Meng-ting GAO, Yi-fei WANG, Li FENG, Wei-feng YAO*, Bei-hua BAO, Yu-dan CAO, Li ZHANG, An-wei DING
Acta Pharmaceutica Sinica | 2020, 55(6) : 1222 - 1228
Less
收藏切换
Acta Pharmaceutica Sinica | 2020, 55(6): 1222-1228
Original Articles
Screening of active ingredients in Erzhi pill for osteoporosis based on molecular docking technology and verification
Full
Yuan-yuan ZHAI, Xin LI, Meng-ting GAO, Yi-fei WANG, Li FENG, Wei-feng YAO*, Bei-hua BAO, Yu-dan CAO, Li ZHANG, An-wei DING
Affiliations
  • Jiangsu Key Laboratory for High Technology Research of TCM Formulae and Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
Published: 2020-06-12 doi: 10.16438/j.0513-4870.2020-0027
Outline
收藏切换

In this study, we used molecular docking technology and validation experiments in vitro to screen the active ingredients of Erzhi pill for treating osteoporosis. Firstly, the compound in Erzhi pill was docked with ten osteoporosis-related targets by molecular docking technology, and the five active compounds, salidroside, specnuezhenide, tyrosol, quercetin, and wedelolactone, were initially selected. Then, MC3T3-E1 osteoblasts were cultured in α-Mem medium containing different concentrations of compounds, and the cell proliferation rate and mineralized nodules were tested. The verification results showed that the proliferation of MC3T3-E1 cells with salidroside, specnuezhenide and quercetin were more obvious, and salidroside has a better effect on the mineralization of MC3T3-E1 cells than those of specnuezhenide and tyrosol. The molecular docking technology coupled with validation experiment in vitro can be used for the screening of anti-osteoporotic active ingredients of Erzhi pill, and it can also provide a method for the study of effective ingredients of traditional Chinese medicine.

Erzhi pill  /  anti-osteoporosis  /  molecular docking  /  active ingredient screening  /  cell verification
Yuan-yuan ZHAI, Xin LI, Meng-ting GAO, Yi-fei WANG, Li FENG, Wei-feng YAO, Bei-hua BAO, Yu-dan CAO, Li ZHANG, An-wei DING. Screening of active ingredients in Erzhi pill for osteoporosis based on molecular docking technology and verification[J]. Acta Pharmaceutica Sinica, 2020 , 55 (6) : 1222 -1228 . DOI: 10.16438/j.0513-4870.2020-0027
Year 2020 volume 55 Issue 6
PDF
117
36
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2020-0027
  • Receive Date:2020-01-07
  • Online Date:2026-01-21
  • Published:2020-06-12
Article Data
Affiliations
History
  • Received:2020-01-07
  • Revised:2020-03-24
Funding
Affiliations
    Jiangsu Key Laboratory for High Technology Research of TCM Formulae and Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2020-0027
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT